Want to see IN:JUBLPHARMA full AI Analyst Report?
Jubilant Pharmova Limited (JUBLPHARMA) Stock Forecast & Price Target
JUBLPHARMA Analyst Ratings
There are no analyst ratings in the last 3 months.
JUBLPHARMA Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
JUBLPHARMA Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, JUBLPHARMA has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. JUBLPHARMA average Analyst price target in the past 3 months is ―.
JUBLPHARMA Financial Forecast
JUBLPHARMA Earnings Forecast
Next quarter’s earnings estimate for JUBLPHARMA is INR 10.50 with a range of INR 10.50 to INR 10.50. The previous quarter’s EPS was INR 4.60. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
JUBLPHARMA Sales Forecast
Next quarter’s sales forecast for JUBLPHARMA is INR 24.07B with a range of INR 24.07B to INR 24.07B. The previous quarter’s sales results were ―. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.